In the new treatment era for exudative age-related macular degeneration (AMD) heralded by the availability of locally administered anti-VEGF drugs, intravitreal monotherapy with triamcinolone injection may no longer be considered as a current therapy for this neovascular condition, said Jost Jonas, MD, at the World Ophthalmology Congress.
Interim results from a Phase I study suggest that intravitreal injection of VEGF Trap (Regeneron Pharmaceuticals) is a promising new approach for the treatment of exudative age-related macular degeneration, said Quan Dong Nguyen, MD, at the World Ophthalmology Congress.
Suggesting a change in the way physicians diagnose glaucoma, Robert Weinreb, MD, outlined a new paradigm for diagnosis of the disease in his Glaucoma Society of International Ophthalmology Congress (GCIOC) Day Lecture, presented Monday at the World Ophthalmology Congress.Dr. Weinreb said that the glaucoma field is undergoing a revolution in diagnosis. He said there is a transition from reliance solely on visual fields to the increased use of structural analysis of the optic disk and RNFL."It's something that was initiated 20 years ago," explained Dr. Weinreb. "Changes are very, very slow in glaucoma, as it does in all medical disciplines. We have reached an infliction point in glaucoma diagnosis where we are about to reap the benefits of this revolution."
There is a wide range of technology available in cataract surgery today and it's easy for ophthalmologists to get excited and carried away by the technology. However, it's the attention to detail; going back to basics about incisions; pre- and post-surgical management; and the proper use of intraocular lenses that also need to be stressed.
Age-related macular degeneration (AMD) is a common cause of vision loss worldwide, particularly in industrialized nations, where it is the main cause of blindness among people of 65 and older, explained Paul Mitchell, MD, at the World Ophthalmology Congress.
Imaging is an essential part of glaucoma management, but while structural damage is frequently apparent before identifiable visual field loss occurs, both functional testing and quantitative imaging should always be performed in eyes with either early or moderate disease, said David F. Garway-Heath, MD.
A target IOP should be set whenever the diagnosis of ocular hypertension or glaucoma is first made, and it should be re-evaluated at each follow-up visit as part of the assessment of the efficacy of treatment for stopping visual field progression and protecting the optic nerve, said Curt Hartleben, MD, at the World Congress of Ophthalmology.
Evidence-based medicine has provided some guidance on the management of herpes simplex virus (HSV) keratitis, but there are still many questions left unanswered, said Thomas J. Liesegang, MD, at the World Congress of Ophthalmology.
Establishing the correct diagnosis and modifying therapy appropriately based on response are fundamental in the successful management of bacterial keratitis, said Richard L. Abbott, MD, at the World Congress of Ophthalmology.
For six days S?o Paulo, Brazil, will be the "Mecca" of ophthalmology. On Sunday, it was "get-acquainted day" as ophthalmic colleagues met to renew friendships with fellow colleagues and friends in industry. The Exhibit Hall opened late in the morning, drawing crowds of physicians to view the latest technology in ophthalmology.
More than 15,000 ophthalmologists from more than 110 countries are registered to attend, and more than 4,000 scientific papers were submitted for consideration. The schedule features more than 400 sessions in addition to subspecialty days, with some 2,400 speakers from all regions of the world.
The 2006 World Ophthalmology Congress (WOC) commenced Sunday in São Paulo, Brazil. With the first non-governmental organization (NGO) forum on vision and blindness prevention. The forum promoted the visibility of non-profit organizations that focus both on blindness prevention and assisting the visually impaired, contributing to an exchange of experiences between entities from all continents and from different socioeconomic realities, as well as organizing and providing a complete record of entities that cater to this area.
Cincinnati—Tamsulosin HCl (Flomax, Boehringer Ingelheim), an alpha-1 blocker used to treat benign prostatic hyperplasia, has been implicated in the development of floppy iris syndrome during cataract surgery, according to Robert H. Osher, MD. Healon 5 (AMO) is his viscoadaptive agent (OVD) of choice to manage this challenging iris behavior during cataract surgery.
San Francisco—The American Academy of Ophthalmology (AAO) has developed an ophthalmology curriculum of more than 800 topics that it believes represent the material that is most relevant to clinical practice.
Chicago—Intraocular lidocaine and corticosteroids can be valuable adjuncts to the cataract surgeon, but they must be used carefully because any drug in an excessive amount can have toxic consequences, said James P. Gills, MD, at Spotlight on Cataract Surgery in 2005 during the annual meeting of the American Academy of Ophthalmology.
Chicago—Awareness of the etiology and treatment of toxic anterior segment syndrome (TASS) is essential because while rare, TASS is a potentially devastating complication of cataract surgery, said Liliana Werner, MD, PhD, during the annual meeting of the American Academy of Ophthalmology.
As the early adopters of the older keratorefractive procedure radial keratotomy (RK) are aging and developing progressive hyperopia and cataracts, it is increasingly important to master safe and effective ways to treat these patients.
Chicago—Insertion of the Perfect Pupil Injectable (PPI, Milvella Pty. Ltd.) is an effective method for protecting the iris and maintaining a large pupil during cataract surgery in eyes predisposed to intraoperative floppy iris syndrome (IFIS), according to the results of an interventional case series reported at the annual meeting of the American Academy of Ophthalmology.
Chicago—All ophthalmologists performing cataract surgery will experience complications at some point. Risk management involves preventing complications, recognizing them when they occur, managing them appropriately, and referring patients in a timely fashion when necessary, said Richard L. Abbott, MD, at the annual meeting of the American Academy of Ophthalmology.
Cincinnati, OH—The viscous dispersive ophthalmic viscosurgical device (OVD) DisCoVisc (Alcon Laboratories Inc.) offers surgeons the opportunity to perform safe and efficient phacoemulsification with a single OVD in routine procedures and in many complex cases as well, said Michael E. Snyder, MD.
Cincinnati—Tamsulosin HCl (Flomax, Boehringer Ingelheim), an alpha-1 blocker used to treat benign prostatic hyperplasia, has been implicated in the development of floppy iris syndrome during cataract surgery, according to Robert H. Osher, MD. Healon 5 (AMO) is his viscoadaptive agent (OVD) of choice to manage this challenging iris behavior during cataract surgery.
Chicago—Management of the subluxated crystalline lens in eyes with profound zonular deficiency has been significantly advanced by developments in anterior segment techniques and new technology, explained Ike Ahmed, MD, at the annual meeting of the American Academy of Ophthalmology.
Barrie, Ontario—The CASE (chamber stabilization environment) component of WhiteStar ICE technology (Advanced Medical Optics) is based on the patented occlusion recognition feature and essentially works to resolve a longstanding issue with phacoemulsification systems—anterior chamber instability and damage associated with postocclusion surge, according to Donald Nixon, MD, of Barrie, Ontario, who was a clinical investigator for this new technology.
Lisbon, Portugal—The use of ultrasonic phaco energy to emulsify cataracts has made surgeries safer and more efficient and has led to smaller incisions and better outcomes. Phaco energy, however, is also detrimental to the corneal endothelium, and the heat that it generates can lead to incision burns. In addition, the amount of phaco energy delivered directly influences the immediate postoperative vision.
New York—The American Association of Dispensing Ophthalmologists (AADO) has endorsed eight continuing education courses, March 31 to April 1, during the International Vision Expo East conference at the Jacob K. Javits Convention Center, New York. The courses presented by AADO, of which Ophthalmology Times is a sponsor, include:
For the 12-month ending (ME) period closing Sept. 30, 2005, the vision-care industry in the United States generated nearly $26.2 billion in revenue, an increase of 3.8% compared with the previous 12-month period.
Chronic trachoma was treated with oily or fatty ointments, which contained myrrh, resin, malachite, yellow ocher, and red natron.
Monrovia, CA—STAAR Surgical Co. expects to begin U.S. shipments this month of the Visian implantable collamer lens (ICL), a foldable, minimally invasive lens approved for the correction of adult myopia.
San Francisco—The American Academy of Ophthalmology (AAO) has developed an ophthalmology curriculum of more than 800 topics that it believes represent the material that is most relevant to clinical practice.
